Renalytix plc American Depositary Shares
RNLX
RNLX was delisted on the 7th of October, 2024.
35 hedge funds and large institutions have $43.8M invested in Renalytix plc American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 5 closing their positions.
78% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 9
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
6% more funds holding
Funds holding: 33 → 35 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
54% less capital invested
Capital invested by funds: $95.5M → $43.8M (-$51.8M)
59% less call options, than puts
Call options by funds: $148K | Put options by funds: $363K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Philosophy Capital Management
Alamo,
California
|
+$4.41M |
| 2 |
PA
Pinnacle Associates
New York
|
+$1.22M |
| 3 |
Millennium Management
New York
|
+$801K |
| 4 |
Barclays
London,
United Kingdom
|
+$720K |
| 5 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$655K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$2.7M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$2.02M |
| 3 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$1.22M |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
-$282K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$241K |
RNLX Hedge Fund Activity: Q1 2022 in Review
35 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Renalytix plc American Depositary Shares (RNLX) for Q1 2022, worth a combined $43.8M — down 54% from $95.5M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new RNLX positions and 5 closed out — a net gain of 2 holders — while 16 added to existing stakes and 9 trimmed.
The largest buyer was Philosophy Capital Management, adding an estimated $4.41M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $2.7M.
- 35 institutional investors held Renalytix plc American Depositary Shares (RNLX) as of Q1 2022, up from 33 in Q4 2021.
- Funds reported $43.8M of Renalytix plc American Depositary Shares stock for Q1 2022, down 54% quarter-over-quarter.
- 7 funds opened new Renalytix plc American Depositary Shares positions in Q1 2022 and 5 closed out, a net change of +2 holders.
- The largest Renalytix plc American Depositary Shares buyer in Q1 2022 was Philosophy Capital Management, an estimated $4.41M added.
- The largest Renalytix plc American Depositary Shares seller in Q1 2022 was Gilder Gagnon Howe & Co, an estimated $2.7M sold.
Based on aggregated 13F filings for Q1 2022.